Abstract
The INternational VErapamil SR/trandolapril STudy (INVEST) will provide a large database of information. Proposed substudies for analysis include ambulatory blood pressure monitoring (ABPM), depression, genotyping, atrial fibrillation, electrocardiogram (ECG), echocardiography, renal dysfunction, diabetes, and cardiac care cost estimate. This paper reviews the design and status of several of the INVEST substudies. The ABPM substudy will obtain objective blood pressure recordings during daily life masked to both the patient and the investigator. Ambulatory blood pressure monitoring is an especially useful technology because of the role of nocturnal hypertension and circadian blood pressure irregularities in the development of hypertensive disease. The depression substudy, which enrolled 2,393 patients in the United States, will report quality‐of‐life (QOL) data, including information regarding energy and fatigue. The genotyping substudy will provide genomic DNA samples from approximately 15,000 patients in the United States, including Puerto Rico. Many candidate genes will be examined for polymorphisms that may predict outcomes and/or responses to various treatments.
Keywords: ambulatory blood pressure monitoring, atrial fibrillation, depression, INVEST substudies, polymorphisms
Full Text
The Full Text of this article is available as a PDF (335.5 KB).
References
- 1. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413–2446 [DOI] [PubMed] [Google Scholar]
- 2. Verdecchia P., Porcellati C., Schillaci G., Borgioni C., Ciucci A., Battistelli M., Guerrieri M., Gatteschi C., Zampi I., Santucci A., Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793–801 [DOI] [PubMed] [Google Scholar]
- 3. Staessen JA, Thijs L., Fagard R., O'Brien ET, Clement D., de Leeuw PW, Mancia G., Nachev C., Palatini P., Parati G., Tuomilehto J., Webster J., Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. J Am Med Assoc 1999; 282: 539–546 [DOI] [PubMed] [Google Scholar]
- 4. Mancia G., Zanchetti A., Agabiti‐Rosei E., Benemio G., De Cesaris R, Fogari R., Pessina A., Porcellati C., Rappelli A., Salvetti A., Trimarco B., Agebiti‐Rosei E., Pessino A., Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment‐induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 1997; 95: 1464–1470 [DOI] [PubMed] [Google Scholar]
- 5. White WB, Analysis of ambulatory blood pressure data in antihypertensive drug trials. J Hypertens 1991: 9 (suppl): S27–32 [PubMed] [Google Scholar]
- 6. Barna I., Keszei A., Dunai A., Evaluation of Meditech ABPM‐04 ambulatory blood pressure measuring device according to the British Hypertension Society protocol. Blood Press Monit 1998; 3: 363–368 [PubMed] [Google Scholar]
- 7. Hu Z., Comparison of the antihypertensive effect and safety of amlodipine and felodipine. Heart Drug 2001; 1: 77–82 [Google Scholar]
- 8. Ried LD, McFarland BH, Johnson RE, Brody KK, Beta‐blockers and depression: The more the murkier? Ann Pharmacother 1998; 32: 699–708 [DOI] [PubMed] [Google Scholar]
- 9. Lindberg G., Bingefors K., Ranstam J., Rastam L., Melander A., Use of calcium channel blockers and risk of suicide: Ecological findings confirmed in population based cohort study. Br Med J 1998; 316: 741–745 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Beevers DG: Beta‐blockers for hypertension: Time to call a halt. J Hum Hypertens 1998; 12: 807–810 [DOI] [PubMed] [Google Scholar]
- 11. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long‐term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. J Am Med Assoc 1982; 248: 2004–2011 [PubMed] [Google Scholar]
- 12. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C., Lakshman R., Gottdiener J., Single‐drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993; 328: 914–921 [DOI] [PubMed] [Google Scholar]
- 13. Pedersen OD, Bagger H., Kober L., Torp‐Pedersen C., Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infaction in patients with left ventricular dysfunction. Circulation 1999; 100: 376–380 [DOI] [PubMed] [Google Scholar]
- 14. Koffi I., Lacolley P., Kirchengaast M., Pomies JP, Laurent S., Benetos A., Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats. Eur J Pharmacol 1998; 361: 51–60 [DOI] [PubMed] [Google Scholar]
- 15. Tieleman RG, De Langen C., Van Gelder IC, de Kam PJ, Grandjean J., Bel KJ, Wijffels MC, Allessie MA, Crijns HJ, Verapamil reduces tachycardia‐induced electrical remodeling of the atria. Circulation 1997; 95: 1945–1953 [DOI] [PubMed] [Google Scholar]